A review of migraine and mood disorders

Psychiatric Annals

Volumn 34, Issue 1, 2004, Pages 33-40

  Low, Nancy C P ^a   Merikangas, James R ^b   Merikangas, Kathleen R ^a  

^a NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

^b GEORGE WASHINGTON UNIVERSITY SCHOOL OF MEDICINE AND HEALTH SCIENCES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ALMOTRIPTAN; ANTICONVULSIVE AGENT; ANTIDEPRESSANT AGENT; ANTIMIGRAINE AGENT; ATENOLOL; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CAFFEINE; CALCIUM CHANNEL BLOCKING AGENT; ELETRIPTAN; ESTROGEN; FLUNARIZINE; FROVATRIPTAN; GLYCERYL TRINITRATE; IBUPROFEN; INDOMETACIN; METOPROLOL; MONOAMINE OXIDASE INHIBITOR; NADOLOL; NAPROXEN; NARATRIPTAN; NICOTINE; NONSTEROID ANTIINFLAMMATORY AGENT; PARACETAMOL; RIZATRIPTAN; SEROTONIN AGONIST; SUMITRIPTAN; TRICYCLIC ANTIDEPRESSANT AGENT; UNCLASSIFIED DRUG; UNINDEXED DRUG; ZOLMITRIPTAN;

BIPOLAR DISORDER; CLINICAL FEATURE; COMORBIDITY; DEPRESSION; DIAGNOSTIC ERROR; DIET THERAPY; DISEASE ASSOCIATION; FATIGUE; FEEDBACK SYSTEM; HEADACHE; HEALTH; HUMAN; LASSITUDE; MAJOR DEPRESSION; MIGRAINE; MOOD DISORDER; PRESCRIPTION; QUALITY OF LIFE; RELAXATION TRAINING; REVIEW; SCHIZOPHRENIA; STATISTICAL SIGNIFICANCE;

EID: 2142755489     PISSN: 00485713     EISSN: None     Source Type: Journal    
DOI: 10.3928/0048-5713-20040101-08     Document Type: Review

References (56)

1. Terwindt GM, Ferrari MD, Tijhuis M, et al. The impact of migraine on quality of life in the general population: the GEM study. Neurology. 2000;55(5):624-629.
2. Murray C, Lopez A. World Health Report 2002: Reducing Risks, Promoting Healthy Life. Available at: http://www.who.int/whr/en. Accessed December 3, 2003.
3. Olesen J. The International Classification of Headache Disorders. 2nd ed. Cephalalgia. 2004;24(Suppl 1).
4. Feinstein A. The pre-therapeutic classification of co-morbidity in chronic disease. J Chronic Dis. 1970;23:455-468.
5. Kaplan MH, Feinstein AR. The importance of classifying initial co-morbidity in evaluation the outcome of diabetes mellitus. J Chronic Dis. 1974;27(7-8):387-404.
6. Pfohl B, Stangl D, Zimmerman M. The implications of DSM-III personality disorders for patients with major depression. J Affect Disord. 1984;7(3-4):309-318.
7. Winokur G, Black DW, Nasrallah A. Depressions secondary to other psychiatric disorders and medical illnesses. Am J Psychiatry. 1988;145(2):233-237.
8. Fulop G, Strain JJ, Vita J, Lyons JS, Hammer JS. Impact of psychiatric comorbidity on length of hospital stay for medical/surgical patients: a preliminary report. Am J Psychiatry. 1987;144(7):878-882.
9. Black DW, Winokur G, Nasrallah A. Is death from natural causes still excessive in psychiatric patients? A follow-up of 1,593 patients with major affective disorder. J Nerv Ment Dis. 1987;175(11):674-680.
10. Liveing E. Migraine, Sick-headache, and Some Allied Disorders: A Contribution to the Pathology of Nerve Storms. London, England: J & A Churchill Press; 1873.
11. Moersch FP. Psychic manifestations of migraine. Am J Psychiatry. 1923;3:697-716.
12. Wolff HG. Personality features and reactions of subjects with migraine. Arch Neurol Psychiatr. 1937;37:895-921.
13. Marazziti D, Toni C, Pedri S, et al. Headache, panic disorder and depression: comorbidity or a spectrum? Neuropsychobiology. 1995;31(3):125-129.
14. Breslau N. Psychiatric comorbidity in migraine. Cephalalgia. 1998;18(Suppl 22):56-61.
15. Swartz KL, Pratt LA, Armenian HK, Lee LC, Eaton WW. Mental disorders and the incidence of migraine headaches in a community sample: results from the Baltimore Epidemiologic Catchment area follow-up study. Arch Gen Psychiatry. 2000;57(10):945-950.
16. Breslau N, Schultz LR, Stewart WF, Lipton R, Welch KM. Headache types and panic disorder: directionality and specificity. Neurology. 2001;56(3):350-354.
17. Merikangas KR, Angst J, Isler H. Migraine and psychopathology. Arch Gen Psychiatry. 1990;47:849-853.
18. Merikangas KR, Merikangas JR, Angst J. Headache syndromes and psychiatric disorders: association and familial transmission. J Psychiatr Res. 1993;27(2):197-210.
19. Juang KD, Wang SJ, Fuh JL, Lu SR, Su TP. Comorbidity of depressive and anxiety disorders in chronic daily headache and its subtypes. Headache. 2000;40(10):818-823.
20. Merikangas KR, Stevens DE, Angst J. Psychopathology and headache syndromes in the community. Headache. 1994;34(8):S17-S22.
21. McElroy SL, Soutullo CA, Beckman DA, Taylor P Jr., Keck PE Jr. DSM-IV intermittent explosive disorder: a report of 27 cases. J Clin Psychiatry. 1998;59(4):203-210.
22. Brewerton TD, George MS, Harden RN. Migraine and the eating disorders. Psychiatry Res. 1993;46(2):201-202.
23. Radat F, Sakh D, Lutz G, el Amrani M, Ferreri M, Bousser MG. Psychiatric comorbidity is related to headache induced by chronic substance use in migraineurs. Headache. 1999;39(7):477-480.
24. Breslau N. Migraine, suicidal ideation, and suicide attempts. Neurology. 1992;42(2):392-395.
25. Breslau N, Davis GC, Andreski P. Migraine, psychiatric disorders, and suicide attempts: an epidemiologic study of young adults. Psychiatry Res. 1991;37(1):11-23.
26. Selby G, Lance J. Observations on 500 cases of migraine and allied vascular headache. J Neurol Neurosurg Psychiatry. 1960;23:23-32.
27. Kashiwagi T, McClure JN Jr., Wetzel RD. Headache and psychiatric disorders. Dis Nerv Syst. 1972;33(10):659-663.
28. Couch JR, Hassanein RS. Headache as a risk factor in atherosclerosis- related diseases. Headache. 1989;29(1):49-54.
29. Morrison DP, Price WH. The prevalence of psychiatric disorder among female new referrals to a migraine clinic. Psychol Med. 1989;19(4):919-925.
30. Glover V, Sandler M. The biochemical basis of migraine predisposition. In: Sandler M, Collins GM, eds. Migraine: A Spectrum of Ideas. New York, NY: Oxford University Press; 1990.
31. Breslau N, Rasmussen BK. The impact of migraine: epidemiology, risk factors, and comorbidities. Neurology. 2001;56(6 Suppl 1):S4-S12.
32. Ferrari MD. Migraine. Lancet. 1998;351(9108):1043-1051.
33. Diamond S. Depressive headaches. Headache. 1964;4:255-259.
34. Philips C, Hunter M. Headache in a psychiatric population. J Nerv Ment Dis. 1982;170(1):34-40.
35. Garvey MJ, Tollefson GD, Schaffer CB. Migraine headaches and depression. Am J Psychiatry. 1984;141(8):986-988.
36. Marchesi C, De Ferri A, Petrolini N, et al. Prevalence of migraine and muscle tension headache in depressive disorders. J Affect Disord. 1989;16(1):33-36.
37. Moldin SO, Scheftner WA, Rice JP, et al. Association between major depressive disorder and physical illness. Psychol Med. 1993;23(3):755-761.
38. Kroenke K, Price RK. Symptoms in the community: Prevalence, classification, and psychiatric comorbidity. Arch Intern Med. 1993;153(21):2474-2480.
39. Breslau N, Schultz LR, Stewart WF, et al. Headache and major depression: is the associatin specific to migraine? Neurology. 2000;54(2):308-313.
40. Patten SB. Long-term medical conditions and major depression in the Canadian population. Can J Psychiatry. 1999;44:151-157.
41. Crisp AH, Kalucy RS, McGuinness B, Ralph PC, Harris G. Some clinical, social and psychological characteristics of migraine subjects in the general population. Postgrad Med J. 1977;53(625):691-697.
42. Paulin JM, Waal-Manning HJ, Simpson FO, Knight RG. The prevalence of headache in a small New Zealand town. Headache. 1985;25(3):147-151.
43. Blehar MC, DePaulo JR Jr., Gershon ES, et al. Women with bipolar disorder: findings from the NIMH Genetics Initiative sample. Psychopharmacol Bull. 1998;34(3):239-243.
44. Cassidy WL, Flanagan NB. Clinical observations in manic-depressive disease. J Am Med Assoc. 1957;164(14):1535-1546.
45. Mahmood T, Romans S, Silverstone T. Prevalence of migraine in bipolar disorder. J Affect Disord. 1999;52(1-3):239-241.
46. Fasmer OB. The prevalence of migraine in patients with bipolar and unipolar affective disorders. Cephalalgia. 2001;21(9):894-899.
47. Younes RP, DeLong GR, Neiman G, Rosner B. Manic-depressive illness in children: treatment with lithium carbonate. J Child Neurol. 1986;1(4):364-368.
48. Low NC, Galbaud du Fort G, Cervantes P. Prevalence, clinical correlates, and treatment of migraine in bipolar disorder. Headache. 2003;43(9):940-949.
49. Fasmer OB, Oedegaard KJ. Clinical characteristics of patients with major affective disorders and comorbid migraine. World J Biol Psychiatry. 2001;2(3):149-155.
50. Robbins L, Ludmer C. Headache: the bipolar spectrum in migraine patients. J Pain. 2000;10:167-170.
51. Akiskal HS, Pinto O. The evolving bipolar spectrum. Prototypes I, II, III, and IV. Psychiatr Clin North Am. 1999;22(3):517-534, vii.
52. Silberstein SD. Practice parameter: evidence-based guidelines for migraine headache (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology. 2000;55(6):754-762.
53. Merikangas KR, Merikangas JR. Combination monoamine oxidase inhibitor and beta-blocker treatment of migraine, with anxiety and depression. Biol Psychiatry. 1995;38(9):603-610.
54. Daroff RB, Whitney CM. Treatment of vascular headaches. Headache. 1986;26(9):470-472.
55. Merikangas JR, Stevens D, Merikangas KR. Enalapril prophylaxis of migraine. Swiss Arch Neurol Psychiatry. 1996;147:118-123.
56. D'Ercole A, Skodol AE, Struening E, Curtis J, Millman J. Diagnosis of physical illness in psychiatric patients using axis III and a standardized medical history. Hosp Community Psychiatry. 1991;42(4):395-400.